161 related articles for article (PubMed ID: 38086727)
1. [Introduction and Reflection on Novel Medical Device Regulatory Science Tool MDDT].
Teng Y; Sheng H; Liu Y
Zhongguo Yi Liao Qi Xie Za Zhi; 2023 Nov; 47(6):674-679. PubMed ID: 38086727
[TBL] [Abstract][Full Text] [Related]
2. Analytical Chemistry in the Regulatory Science of Medical Devices.
Wang Y; Guan A; Wickramasekara S; Phillips KS
Annu Rev Anal Chem (Palo Alto Calif); 2018 Jun; 11(1):307-327. PubMed ID: 29579404
[TBL] [Abstract][Full Text] [Related]
3. Initial interactions with the FDA on developing a validation dataset as a medical device development tool.
Hart S; Garcia V; Dudgeon SN; Hanna MG; Li X; Blenman KR; Elfer K; Ly A; Salgado R; Saltz J; Gupta R; Hytopoulos E; Larsimont D; Lennerz J; Gallas BD
J Pathol; 2023 Dec; 261(4):378-384. PubMed ID: 37794720
[TBL] [Abstract][Full Text] [Related]
4. Qualification of a non-animal vaginal irritation method admitted as nonclinical assessment model (NAM) in the Incubator Phase of the United States Food and Drug Administration (US FDA) Medical Devices Development Tool (MDDT).
Costin GE; Hill E; Brown J; Clippinger AJ
Toxicol In Vitro; 2020 Feb; 62():104680. PubMed ID: 31626901
[TBL] [Abstract][Full Text] [Related]
5. FDA regulation of invasive neural recording electrodes: a daunting task for medical innovators.
Welle C; Krauthamer V
IEEE Pulse; 2012 Mar; 3(2):37-41. PubMed ID: 22481744
[TBL] [Abstract][Full Text] [Related]
6. Easing Medical Device Regulatory Oversight: The FDA and Testing Amidst the COVID-19 Pandemic.
Maxwell K
Am J Law Med; 2021 Jul; 47(2-3):291-326. PubMed ID: 34405782
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Medical Devices for Dermatology.
Halachmi S; Marquart L
Dermatol Clin; 2022 Jul; 40(3):297-305. PubMed ID: 35750413
[TBL] [Abstract][Full Text] [Related]
8. Integrated Devices: A New Regulatory Pathway to Promote Revolutionary Innovation.
Cho T; Gowda V; Schulzrinne H; Miller BJ
Milbank Q; 2024 Jun; 102(2):367-382. PubMed ID: 38253988
[TBL] [Abstract][Full Text] [Related]
9. FDA Regulation and Approval of Medical Devices: 1976-2020.
Darrow JJ; Avorn J; Kesselheim AS
JAMA; 2021 Aug; 326(5):420-432. PubMed ID: 34342614
[TBL] [Abstract][Full Text] [Related]
10. Combination products: modernizing the regulatory paradigm.
Hunter NL; Sherman RE
Nat Rev Drug Discov; 2017 Aug; 16(8):513-514. PubMed ID: 28496147
[TBL] [Abstract][Full Text] [Related]
11. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
Ronquillo JG; Zuckerman DM
Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
[TBL] [Abstract][Full Text] [Related]
12. FDA regulation of cardiovascular devices and opportunities for improvement.
Dhruva SS; Redberg RF
J Interv Card Electrophysiol; 2013 Mar; 36(2):99-105. PubMed ID: 23263896
[TBL] [Abstract][Full Text] [Related]
13. New technology in electrophysiology: FDA process and perspective.
Selzman KA; Fellman M; Farb A; de Del Castillo S; Zuckerman B
J Interv Card Electrophysiol; 2016 Oct; 47(1):11-18. PubMed ID: 27020440
[TBL] [Abstract][Full Text] [Related]
14. Ensuring medical device effectiveness and safety: a cross--national comparison of approaches to regulation.
Kramer DB; Tan YT; Sato C; Kesselheim AS
Food Drug Law J; 2014; 69(1):1-23, i. PubMed ID: 24772683
[TBL] [Abstract][Full Text] [Related]
15. Bringing smart pills to market: FDA regulation of ingestible drug/device combination products.
Avery M; Liu D
Food Drug Law J; 2011; 66(3):329-52, i. PubMed ID: 24505852
[TBL] [Abstract][Full Text] [Related]
16. Oversight overhaul: eliminating the premarket review of medical devices and implementing a provider-centered postmarket surveillance strategy.
Scott B
Food Drug Law J; 2011; 66(3):377-404, ii. PubMed ID: 24505854
[TBL] [Abstract][Full Text] [Related]
17. Improving medical device regulation: the United States and Europe in perspective.
Sorenson C; Drummond M
Milbank Q; 2014 Mar; 92(1):114-50. PubMed ID: 24597558
[TBL] [Abstract][Full Text] [Related]
18. Regulation of medical devices in radiology: current standards and future opportunities.
Smith JJ
Radiology; 2001 Feb; 218(2):329-35. PubMed ID: 11161144
[TBL] [Abstract][Full Text] [Related]
19. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
[TBL] [Abstract][Full Text] [Related]
20. The U. S. Food and Drug Administration's role in contact lens development and safety.
Saviola JF; Hilmantel G; Rosenthal AR
Eye Contact Lens; 2003 Jan; 29(1 Suppl):S160-5; discussion S166, S192-4. PubMed ID: 12772757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
